RAFFA WEALTH MANAGEMENT, LLC’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-6
| Closed | -$55 | – | 1209 |
|
|
2025
Q2 | $55 | Hold |
6
| – | – | ﹤0.01% | 1096 |
|
|
2025
Q1 | $48 | Hold |
6
| – | – | ﹤0.01% | 1071 |
|
|
2024
Q4 | $33 | Hold |
6
| – | – | ﹤0.01% | 1108 |
|
|
2024
Q3 | $43 | Hold |
6
| – | – | ﹤0.01% | 1077 |
|
|
2024
Q2 | $65 | Hold |
6
| – | – | ﹤0.01% | 1145 |
|
|
2024
Q1 | $112 | Hold |
6
| – | – | ﹤0.01% | 1112 |
|
|
2023
Q4 | $130 | Hold |
6
| – | – | ﹤0.01% | 1042 |
|
|
2023
Q3 | $123 | Hold |
6
| – | – | ﹤0.01% | 1043 |
|
|
2023
Q2 | $282 | Hold |
6
| – | – | ﹤0.01% | 1018 |
|
|
2023
Q1 | $252 | Hold |
6
| – | – | ﹤0.01% | 1027 |
|
|
2022
Q4 | $229 | Hold |
6
| – | – | ﹤0.01% | 1018 |
|
|
2022
Q3 | $235 | Hold |
6
| – | – | ﹤0.01% | 1117 |
|
|
2022
Q2 | $194 | Hold |
6
| – | – | ﹤0.01% | 1105 |
|
|
2022
Q1 | $199 | Hold |
6
| – | – | ﹤0.01% | 1119 |
|
|
2021
Q4 | $255 | Hold |
6
| – | – | ﹤0.01% | 1111 |
|
|
2021
Q3 | $266 | Hold |
6
| – | – | ﹤0.01% | 1097 |
|
|
2021
Q2 | $341 | Hold |
6
| – | – | ﹤0.01% | 1073 |
|
|
2021
Q1 | $449 | Hold |
6
| – | – | ﹤0.01% | 1065 |
|
|
2020
Q4 | $519 | Hold |
6
| – | – | ﹤0.01% | 861 |
|
|
2020
Q3 | $367 | Hold |
6
| – | – | ﹤0.01% | 844 |
|
|
2020
Q2 | $249 | Hold |
6
| – | – | ﹤0.01% | 874 |
|
|
2020
Q1 | $172 | Hold |
6
| – | – | ﹤0.01% | 846 |
|
|
2019
Q4 | $433 | Hold |
6
| – | – | ﹤0.01% | 731 |
|
|
2019
Q3 | $842 | Buy |
+6
| New | +$1K | ﹤0.01% | 655 |
|
|
2019
Q2 | – | Sell |
-6
| Closed | -$954 | – | 1263 |
|
|
2019
Q1 | $954 | Hold |
6
| – | – | ﹤0.01% | 585 |
|
|
2018
Q4 | $575 | Hold |
6
| – | – | ﹤0.01% | 709 |
|
|
2018
Q3 | $848 | Hold |
6
| – | – | ﹤0.01% | 687 |
|
|
2018
Q2 | $939 | Hold |
6
| – | – | ﹤0.01% | 625 |
|
|
2018
Q1 | $966 | Buy |
+6
| New | +$1.02K | ﹤0.01% | 579 |
|
|
2017
Q3 | – | Sell |
-12
| Closed | -$956 | – | 368 |
|
|
2017
Q2 | $956 | Hold |
12
| – | – | ﹤0.01% | 357 |
|
|
2017
Q1 | $853 | Hold |
12
| – | – | ﹤0.01% | 344 |
|
|
2016
Q4 | $613 | Sell |
12
-1
| -8% | -$47 | ﹤0.01% | 657 |
|
|
2016
Q3 | $599 | Sell |
13
-5
| -28% | -$204 | ﹤0.01% | 640 |
|
|
2016
Q2 | $542 | Hold |
18
| – | – | ﹤0.01% | 643 |
|
|
2016
Q1 | $577 | Hold |
18
| – | – | ﹤0.01% | 635 |
|
|
2015
Q4 | $1.05K | Buy |
18
+9
| +100% | +$446 | ﹤0.01% | 376 |
|
|
2015
Q3 | $381 | Hold |
9
| – | – | ﹤0.01% | 756 |
|
|
2015
Q2 | $657 | Buy |
+9
| New | +$579 | ﹤0.01% | 556 |
|
Other funds holding SAGE
IA
HNB
RAFFA WEALTH MANAGEMENT, LLC's SAGE Position: Q3 2025 in Review
RAFFA WEALTH MANAGEMENT, LLC sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 6 shares — an estimated $55 sold.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in SAGE in Q2 2015 and held it in 38 quarters. The position peaked at $1.05K in Q4 2015. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.
- RAFFA WEALTH MANAGEMENT, LLC reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
- RAFFA WEALTH MANAGEMENT, LLC sold 6 Sage Therapeutics shares in Q3 2025, an estimated $55.
- RAFFA WEALTH MANAGEMENT, LLC first reported a position in Sage Therapeutics in Q2 2015 and held it in 38 quarters.
- RAFFA WEALTH MANAGEMENT, LLC's Sage Therapeutics position peaked at $1.05K in Q4 2015.
- 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.
Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q3 2025, filed 27 Jul 2026.